|
1
|
De Plaen E, Arden K, Traversari C, Gaforio
JJ, Szikora JP, De Smet C, Brasseur F, van der Bruggen P, Lethé B,
Lurquin C, et al: Structure, chromosomal localization, and
expression of 12 genes of the MAGE family. Immunogenetics.
40:360–369. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Caballero OL and Chen YT: Cancer/testis
(CT) antigens: Potential targets for immunotherapy. Cancer Sci.
100:2014–2021. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takahashi N, Ohkuri T, Homma S, Ohtake J,
Wakita D, Togashi Y, Kitamura H, Todo S and Nishimura T: First
clinical trial of cancer vaccine therapy with artificially
synthesized helper/killer-hybrid epitope long peptide of MAGE-A4
cancer antigen. Cancer Sci. 103:150–153. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Saito T, Wada H, Yamasaki M, Miyata H,
Nishikawa H, Sato E, Kageyama S, Shiku H, Mori M and Doki Y: High
expression of MAGE-A4 and MHC class I antigens in tumor cells and
induction of MAGE-A4 immune responses are prognostic markers of
CHP-MAGE-A4 cancer vaccine. Vaccine. 32:5901–5907. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Marcar L, Maclaine NJ, Hupp TR and Meek
DW: Mage-A cancer/testis antigens inhibit p53 function by blocking
its interaction with chromatin. Cancer Res. 70:10362–10370. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bhan S, Chuang A, Negi SS, Glazer CA and
Califano JA: MAGEA4 induces growth in normal oral keratinocytes by
inhibiting growth arrest and apoptosis. Oncol Rep. 28:1498–1502.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Duan Z, Duan Y, Lamendola DE, Yusuf RZ,
Naeem R, Penson RT and Seiden MV: Overexpression of MAGE/GAGE genes
in paclitaxel/doxorubicin-resistant human cancer cell lines. Clin
Cancer Res. 9:2778–2785. 2003.PubMed/NCBI
|
|
8
|
Peikert T, Specks U, Farver C, Erzurum SC
and Comhair SA: Melanoma antigen A4 is expressed in non-small cell
lung cancers and promotes apoptosis. Cancer Res. 66:4693–4700.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nagao T, Higashitsuji H, Nonoguchi K,
Sakurai T, Dawson S, Mayer RJ, Itoh K and Fujita J: MAGE-A4
interacts with the liver oncoprotein gankyrin and suppresses its
tumorigenic activity. J Biol Chem. 278:10668–10674. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sakurai T, Itoh K, Higashitsuji H, Nagao
T, Nonoguchi K, Chiba T and Fujita J: A cleaved form of MAGE-A4
binds to Miz-1 and induces apoptosis in human cells. J Biol Chem.
279:15505–15514. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gure AO, Chua R, Williamson B, Gonen M,
Ferrera CA, Gnjatic S, Ritter G, Simpson AJ, Chen YT, Old LJ, et
al: Cancer-testis genes are coordinately expressed and are markers
of poor outcome in non-small cell lung cancer. Clin Cancer Res.
11:8055–8062. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Groeper C, Gambazzi F, Zajac P, Bubendorf
L, Adamina M, Rosenthal R, Zerkowski HR, Heberer M and Spagnoli GC:
Cancer/testis antigen expression and specific cytotoxic T
lymphocyte responses in non small cell lung cancer. Int J Cancer.
120:337–343. 2007. View Article : Google Scholar
|
|
13
|
Yoshida N, Abe H, Ohkuri T, Wakita D, Sato
M, Noguchi D, Miyamoto M, Morikawa T, Kondo S, Ikeda H, et al:
Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T
cell infiltration in non-small cell lung carcinoma and their
prognostic significance. Int J Oncol. 28:1089–1098. 2006.PubMed/NCBI
|
|
14
|
Shigematsu Y, Hanagiri T, Shiota H, Kuroda
K, Baba T, Mizukami M, So T, Ichiki Y, Yasuda M, So T, et al:
Clinical significance of cancer/testis antigens expression in
patients with non-small cell lung cancer. Lung Cancer. 68:105–110.
2010. View Article : Google Scholar
|
|
15
|
Rimoldi D, Salvi S, Schultz-Thater E,
Spagnoli GC and Cerottini JC: Anti-MAGE-3 antibody 57B and
anti-MAGE-1 antibody 6C1 can be used to study different proteins of
the MAGE-A family. Int J Cancer. 86:749–751. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Landry C, Brasseur F, Spagnoli GC, Marbaix
E, Boon T, Coulie P and Godelaine D: Monoclonal antibody 57B stains
tumor tissues that express gene MAGE-A4. Int J Cancer. 86:835–841.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sobin L, Gospodarowics M and Wittekind C:
International Union Against Cancer: TNM Classification of Malignant
Tumours. Wiley-Blackwell; Chichester, West Sussex: 2009
|
|
18
|
Ichinokawa M, Miyamoto M, Tanaka K,
Kyogoku N, Kuroda A, Maki T, Yamamura Y and Hirano S: Sequence
confirmation and characterization of the mouse Ssxa gene: Ssxa
protein is cleaved and the N-terminal cleaved fragment translocates
into the nucleus. Int J Mol Med. 28:705–710. 2011.PubMed/NCBI
|
|
19
|
Ishikawa K, Miyamoto M, Yoshioka T, Kadoya
M, Li L, Mishra R, Ichinokawa K, Shoji Y, Matsumura Y, Hida Y, et
al: Method for the validation of immunohistochemical staining using
SCID mouse xenografts: Expression of CD40 and CD154 in human
non-small cell lung cancer. Oncol Rep. 29:1315–1321. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kyogoku N, Ikeda H, Tsuchikawa T, Abiko T,
Fujiwara A, Maki T, Yamamura Y, Ichinokawa M, Tanaka K, Imai N, et
al: Time-dependent transition of the immunoglobulin G subclass and
immunoglobulin E response in cancer patients vaccinated with
cholesteryl pullulan-melanoma antigen gene-A4 nanogel. Oncol Lett.
12:4493–4504. 2016. View Article : Google Scholar
|
|
21
|
Miyauchi K, Tsuchikawa T, Wada M, Abiko T,
Kyogoku N, Shichinohe T, Miyahara Y, Kageyama S, Ikeda H, Shiku H,
et al: Clinical relevance of antigen spreading pattern induced by
CHP-MAGE-A4 cancer vaccination. Immunotherapy. 8:527–540. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sakurai T, Kudo M, Itoh K, Ryu U,
Higashitsuji H and Fujita J: Adriamycin enhances
proteasome-mediated generation of the proapoptotic processed form
of MAGE-A4 in hepatoma cells. Oncology. 81(Suppl 1): 30–35. 2011.
View Article : Google Scholar
|
|
23
|
Yang B, O' Herrin SM, Wu J, Reagan-Shaw S,
Ma Y, Bhat KM, Gravekamp C, Setaluri V, Peters N, Hoffmann FM, et
al: MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1
and suppress p53-dependent apoptosis in MAGE-positive cell lines.
Cancer Res. 67:9954–9962. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nielsen S: Flex Ready-to-Use Atlas of
Stains. Dako; Santa Clara, CA: 2012
|
|
25
|
Steels E, Paesmans M, Berghmans T, Branle
F, Lemaitre F, Mascaux C, Meert AP, Vallot F, Lafitte JJ and
Sculier JP: Role of p53 as a prognostic factor for survival in lung
cancer: A systematic review of the literature with a meta-analysis.
Eur Respir J. 18:705–719. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mitsudomi T, Hamajima N, Ogawa M and
Takahashi T: Prognostic significance of p53 alterations in patients
with non-small cell lung cancer: A meta-analysis. Clin Cancer Res.
6:4055–4063. 2000.PubMed/NCBI
|
